Schedule 13D ownership disclosure

ADURO BIOTECH, INC.

Security class unavailable · CUSIP: 00739L101

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,861,106
Percent of class
4.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-024059
Form type
SC 13D/A
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub